tiprankstipranks
Passage Bio reports Q3 EPS (31c), consensus (23c)
PremiumThe FlyPassage Bio reports Q3 EPS (31c), consensus (23c)
2M ago
PASG Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PASG Upcoming Earnings Report: What to Expect?
2M ago
Passage Bio Presents Promising Data on PBFT02 Therapy
Premium
Company Announcements
Passage Bio Presents Promising Data on PBFT02 Therapy
3M ago
Passage Bio Appoints Thomas Kassberg to Leadership Team
PremiumCompany AnnouncementsPassage Bio Appoints Thomas Kassberg to Leadership Team
4M ago
Passage Bio initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Passage Bio initiated with a Buy at Rodman & Renshaw
5M ago
Passage Bio Presents Updated Corporate Insights
Premium
Company Announcements
Passage Bio Presents Updated Corporate Insights
5M ago
Passage Bio received positive feedback in Type C meeting with FDA on PBFT02
PremiumThe FlyPassage Bio received positive feedback in Type C meeting with FDA on PBFT02
6M ago
Passage Bio price target lowered to $13 from $14 at Canaccord
Premium
The Fly
Passage Bio price target lowered to $13 from $14 at Canaccord
8M ago
Passage Bio Unveils Updated Corporate Presentation
Premium
Company Announcements
Passage Bio Unveils Updated Corporate Presentation
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100